- Home
- FORM vs RDY Comparison
FORM vs RDY Comparison
Compare FORM & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- RDY
- Stock Information
- Founded
- FORM 1993
- RDY 1984
- Country
- FORM United States
- RDY India
- Employees
- FORM N/A
- RDY N/A
- Industry
- FORM Semiconductors
- RDY Biotechnology: Pharmaceutical Preparations
- Sector
- FORM Technology
- RDY Health Care
- Exchange
- FORM Nasdaq
- RDY Nasdaq
- Market Cap
- FORM 2.2B
- RDY 2.1B
- IPO Year
- FORM N/A
- RDY N/A
- Fundamental
- Price
- FORM $29.86
- RDY $14.64
- Analyst Decision
- FORM Buy
- RDY Buy
- Analyst Count
- FORM 7
- RDY 1
- Target Price
- FORM $41.17
- RDY $17.00
- AVG Volume (30 Days)
- FORM 607.4K
- RDY 1.6M
- Earning Date
- FORM 07-30-2025
- RDY 05-09-2025
- Dividend Yield
- FORM N/A
- RDY 0.65%
- EPS Growth
- FORM N/A
- RDY 1.46
- EPS
- FORM 0.69
- RDY 0.79
- Revenue
- FORM $766,230,000.00
- RDY $3,809,801,863.00
- Revenue This Year
- FORM $2.18
- RDY $10.24
- Revenue Next Year
- FORM $7.14
- RDY N/A
- P/E Ratio
- FORM $43.22
- RDY $18.43
- Revenue Growth
- FORM 15.33
- RDY 16.61
- 52 Week Low
- FORM $22.58
- RDY $12.26
- 52 Week High
- FORM $63.63
- RDY $16.89
- Technical
- Relative Strength Index (RSI)
- FORM 46.02
- RDY 61.01
- Support Level
- FORM $29.40
- RDY $14.24
- Resistance Level
- FORM $32.30
- RDY $14.77
- Average True Range (ATR)
- FORM 1.04
- RDY 0.17
- MACD
- FORM -0.28
- RDY 0.02
- Stochastic Oscillator
- FORM 7.94
- RDY 79.05
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.